Certified by Founder Lodge
PulmoBioMed Ltd.
United Kingdom - Newcastle upon Tyne, England
START UP
1 Disclosed Funding Rounds $1,765,330
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
PulmoBioMed commercialises state-of-the-art exhaled breath condensate & aerosol sampling technology as part of a platform for disease and environmental diagnostics.
Our lead product, PBM-H
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 09 ,2024 | Unknown | $1,765,330 |
SFC Capital
The North East Fund Ltd.
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
